Search results
Results From The WOW.Com Content Network
In 1996, Reata opened its second location [5] in Fort Worth, Texas, on the 35th floor of the Bank One Tower. Following the F3 tornado on March 28, 2000, Reata was hit and forced to close. [6] [7] [8] Within six weeks, the restaurant was rebuilt and became operational in the original location that was hit by the tornado. In January 2001, the ...
In the late 1990s, Mi Cocina's parent company M Crowd Restaurant Group opened sibling restaurant Taco Diner, which served Mexico City-style tacos and Mambo Taxis in Dallas. It was known as a rare spot to eat sit-down tacos in Dallas. After most of its locations closed between 2019 and 2021, the last location shut its doors on January 13, 2024. [7]
Washburne is a co-founder of the M Crowd Restaurant Group, owning forty-six restaurants, including the Mi Cocina and Taco Diner restaurant chains. [2] [3] He also has real-estate developments in several states and is the CEO of Charter Holdings.
3 New Chick-fil-A locations in Dallas-Fort Worth. A new Chick-fil-A is going to be built in Dallas at 11809 E. Northwest Highway, according to records filed Wednesday with the state.This location ...
Head office location Original location Year started Number of locations Notes Acapulco Mexican Restaurant and Cantina: Cypress, California: Pasadena, California: 1960 4 El Adobe de Capistrano: San Juan Capistrano, California: San Juan Capistrano, California: 1948 1 Amor y Tacos: Cerritos, California: Cerritos, California: 2013 1 Anna's Taqueria
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Sundance Square. Sundance Square is the name of a 35-block commercial, residential, entertainment and retail district in downtown Fort Worth, Texas.Named after the Sundance Kid in western folklore, it is a popular place for nightlife and entertainment in Fort Worth and for tourists visiting the Dallas/Fort Worth Metroplex.
Two high-yield stocks worth buying. For income investors, these pharmaceutical giants offer two distinct paths forward. Bristol-Myers Squibb provides a higher 4.3% yield and an acquisition-driven ...